Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Technology
E-136-2018
Patent ID
E-136-2018-1-PCT-01
Country
PCT
Application Type
PCT
Patent Status
Expired
Patent Number
Publication Number
WO 2017/142871
Application Number
PCT/US2017/017804
IC
NCI
Date Filed
Date Issued
Patent PDF